The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.